Dr. Pao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
975 Port Washington Rd
Grafton, WI 53024Phone+1 262-329-5000Fax+1 262-329-5205
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 1983 - 1987
Medical College of WisconsinClass of 1983
Certifications & Licensure
WI State Medical License 1989 - 2025
TN State Medical License 1987 - 1990- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 2056 citationsSomatic mutations affect key pathways in lung adenocarcinomaLi Ding, Gad Getz, David A. Wheeler, Elaine R. Mardis, Michael D. McLellan
Nature. 2008-10-23 - 600 citationsClinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or ErlotinibGregory J. Riely, William Pao, Duy Pham, Allan R. Li, Naiyer A. Rizvi
Clinical Cancer Research. 2006-02-01 - 82 citationsPhase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.Daniel T. Milton, Gregory J. Riely, Christopher G. Azzoli, Jorge Gomez, Robert T. Heelan
Cancer. 2007-08-01
Grant Support
- Overcoming Acquired Resistance To EGFR Inhibitors In Lung CancerNational Cancer Institute2009–2011
- EGFR Kinase Inhibitor-Persistent Egfr-Mutant Lung AdenocarcinomaNational Cancer Institute2007–2011
- Overcoming Acquired Resistance To EGFR Inhibitors In Lung CancerNational Cancer Institute2007–2008
- Elucidating Mechanisms Of Lung Tumor RegressionNational Cancer Institute2005–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
